Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (621-630 of 726) with videos related to

Pageof 73
Sort By:
Chemmedchem|July 16, 2011
Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208Jane V Aldrich, Santosh S Kulkarni, Sanjeewa N Senadheera, et al.
Breast (Edinburgh, Scotland)|November 6, 2022
Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancerEoin P Kerin, Matthew G Davey, Ray P McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphomaA H Sarris, A Younes, P McLaughlin, et al.
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.
Proteomics|January 26, 2022
Novel histone modifications in microglia derived from a mouse model of chronic painPing Zhang, Jennifer Guergues, Amy R Alleyne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Hodgkin's disease: study of treatment intensities and incidences of second malignanciesM A Rodriguez, L M Fuller, S O Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019Tucker Maxson, Thiphasone Kongphet-Tran, Thitipong Mongkolrattanothai, et al.
Journal of the American Chemical Society|November 22, 2012
Azurin as a protein scaffold for a low-coordinate nonheme iron site with a small-molecule binding pocketMatthew P McLaughlin, Marius Retegan, Eckhard Bill, et al.
Plos One|December 30, 2017
Phylogenetic inference of Coxiella burnetii by 16S rRNA gene sequencingHeather P McLaughlin, Blake Cherney, Janetta R Hakovirta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatmentT A Davis, A J Grillo-López, C A White, et al.
Pageof 73

Showing results (621-630 of 726) with videos related to

Sort By:
Pageof 73
Chemmedchem|July 16, 2011
Unexpected opioid activity profiles of analogues of the novel peptide kappa opioid receptor ligand CJ-15,208Jane V Aldrich, Santosh S Kulkarni, Sanjeewa N Senadheera, et al.
Breast (Edinburgh, Scotland)|November 6, 2022
Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancerEoin P Kerin, Matthew G Davey, Ray P McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphomaA H Sarris, A Younes, P McLaughlin, et al.
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.
Proteomics|January 26, 2022
Novel histone modifications in microglia derived from a mouse model of chronic painPing Zhang, Jennifer Guergues, Amy R Alleyne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Hodgkin's disease: study of treatment intensities and incidences of second malignanciesM A Rodriguez, L M Fuller, S O Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019Tucker Maxson, Thiphasone Kongphet-Tran, Thitipong Mongkolrattanothai, et al.
Journal of the American Chemical Society|November 22, 2012
Azurin as a protein scaffold for a low-coordinate nonheme iron site with a small-molecule binding pocketMatthew P McLaughlin, Marius Retegan, Eckhard Bill, et al.
Plos One|December 30, 2017
Phylogenetic inference of Coxiella burnetii by 16S rRNA gene sequencingHeather P McLaughlin, Blake Cherney, Janetta R Hakovirta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatmentT A Davis, A J Grillo-López, C A White, et al.
Pageof 73